We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Enzyme Responsible for Skin Thickening Disorder Linked to Esophageal Cancer

By LabMedica International staff writers
Posted on 17 Feb 2017
Print article
Image: A photomicrograph of keratin filaments inside cells (Photo courtesy of Wikimedia Commons).
Image: A photomicrograph of keratin filaments inside cells (Photo courtesy of Wikimedia Commons).
A recent paper explained the molecular mechanism underlying the development of palmoplantar keratoderma (thickening of the skin on the palms of the hands and soles of the feet) in the rare genetic disease Tylosis with esophageal cancer (TOC).

This condition is inherited as an autosomal dominant syndrome and is characterized by palmoplantar keratoderma, oral precursor lesions particularly on the gums (leukoplakia), and a high lifetime risk of esophageal cancer (95% develop esophageal cancer by the age of 65).

Investigators at Queen Mary University of London reported in the January 27, 2017, online edition of the journal Nature Communications, that the inactive rhomboid protease RHBDF2 (Rhomboid family member 2 - the alternative name iRhom2 has been proposed, in order to clarify that it is a catalytically inactive member of the rhomboid family of intramembrane serine proteases) regulates thickening of the footpad epidermis through its interaction with keratin 16 (K16). K16 is a cytoskeletal scaffolding protein highly expressed at pressure-bearing sites of the mammalian footpad, which can be induced in hyperproliferative states such as wound healing, inflammation, and cancer.

The investigators found that mice that had been genetically engineered to lack the iRHOM2 gene had abnormally thin paw skin, while humans with mutations that increased the expression of iRHOM2 had thickened palms and soles with callouses, and that a high percentage of these patients developed esophageal cancer.

At the molecular level, the investigators found that iRHOM2 bound to K16, and that this interaction was increased in TOC keratinocytes, where it was associated with robust downregulation of K16’s binding partner K6. In humans and mice, iRHOM2 loss resulted in dampened proliferation and reduced K16 expression, and in mice this led to thinning of epidermis in the footpad.

The authors concluded that, "These findings contribute to our understanding of the molecular mechanisms underlying hyperproliferation of the palmoplantar epidermis in both physiological and disease states, and how this "stress" keratin is regulated. These findings highlight a novel and fundamental role for iRHOM2 in regulating the epithelial response to mechanical stress."

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.